HOLOGIC INC Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 48 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-12-06: Reporting owner MACMILLAN STEPHEN P; Form 4; Security Restricted Stock Unit Award (Right To Receive); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-12-06: Reporting owner MACMILLAN STEPHEN P; Form 4; Security Restricted Stock Unit Award (Right To Receive); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-11-18: Reporting owner Oberton Karleen Marie; Form 4; Security Restricted Stock Unit Award (Right To Receive); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-11-07: Reporting owner Oberton Karleen Marie; Form 4; Security Restricted Stock Unit Award (Right To Receive); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-12-06 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,628 0 owned after | no price filed | 2017-12-08 | |
| 2017-12-06 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −28,040 0 owned after | no price filed | 2017-12-08 | |
| 2017-11-18 | Oberton Karleen Marie Officer (Corp. VP & Chief Acctg Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,515 0 owned after | no price filed | 2017-11-21 | |
| 2017-11-07 | Oberton Karleen Marie Officer (Corp. VP & Chief Acctg Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,860 1,860 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | Compton Eric B. Officer (COO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,636 3,637 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | Compton Eric B. Officer (COO) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +29,091 58,182 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | Compton Eric B. Officer (COO) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −58,182 0 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | Bebo Allison P Officer (SVP, Human Resources) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,024 14,048 owned after | $0.00 | 2017-11-09 | |
| 2017-11-07 | Bebo Allison P Officer (SVP, Human Resources) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,048 0 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +138,782 277,564 owned after | $0.00 | 2017-11-09 | |
| 2017-11-07 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,348 17,348 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −277,564 0 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,261 30,522 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,907 1,908 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,522 0 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,615 57,230 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,577 3,577 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −57,230 0 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | Griffin John M. Officer (General Counsel) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,743 21,486 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | Griffin John M. Officer (General Counsel) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,264 16,528 owned after | $0.00 | 2017-11-09 | |
| 2017-11-07 | Griffin John M. Officer (General Counsel) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,486 0 owned after | no price filed | 2017-11-09 | |
| 2017-11-07 | Griffin John M. Officer (General Counsel) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,528 0 owned after | no price filed | 2017-11-09 | |
| 2017-11-05 | Compton Eric B. Officer (COO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,128 3,128 owned after | no price filed | 2017-11-09 | |
| 2017-11-05 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,119 15,119 owned after | no price filed | 2017-11-09 | |
| 2017-11-05 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,085 2,086 owned after | no price filed | 2017-11-09 | |
| 2017-11-05 | West Thomas A. Officer (Div President & GM, Diagnostic) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,085 2,086 owned after | no price filed | 2017-11-09 | |
| 2017-11-05 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,403 3,304 owned after | no price filed | 2017-11-09 | |
| 2017-11-05 | Griffin John M. Officer (General Counsel) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,502 2,503 owned after | no price filed | 2017-11-09 | |
| 2017-11-05 | Oberton Karleen Marie Officer (Corp. VP & Chief Acctg Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −797 775 owned after | no price filed | 2017-11-07 | |
| 2017-10-03 | West Thomas A. Officer (Div President & GM, Diagnostic) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,063 4,064 owned after | no price filed | 2017-10-05 | |
| 2017-05-26 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,411 3,411 owned after | $23.82 exercise price | 2017-05-31 | |
| 2017-05-26 | Oberton Karleen Marie Officer (Corp. VP & Chief Acctg Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −525 525 owned after | no price filed | 2017-05-31 | |
| 2017-05-26 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,347 7,347 owned after | no price filed | 2017-05-31 | |
| 2017-04-14 | Compton Eric B. Officer (COO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,188 4,189 owned after | no price filed | 2017-04-18 | |
| 2017-04-14 | Compton Eric B. Officer (COO) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,465 70,367 owned after | no price filed | 2017-04-18 | |
| 2017-04-14 | Compton Eric B. Officer (COO) | 4 | Performance Stock Unit Award (Right to Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −70,367 0 owned after | no price filed | 2017-04-18 | |
| 2017-03-08 | ULLIAN ELAINE Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,260 0 owned after | no price filed | 2017-03-09 | |
| 2017-03-08 | GARRETT SCOTT T Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,427 0 owned after | no price filed | 2017-03-09 | |
| 2017-03-08 | COUGHLIN CHRISTOPHER J Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,427 0 owned after | no price filed | 2017-03-09 | |
| 2017-03-08 | CRAWFORD SALLY Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,427 0 owned after | no price filed | 2017-03-09 | |
| 2017-03-08 | Stamoulis Christiana Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,427 0 owned after | no price filed | 2017-03-09 | |
| 2017-03-08 | Levy Lawrence M Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,427 0 owned after | no price filed | 2017-03-09 | |
| 2017-03-08 | LEAMING NANCY Director | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,427 0 owned after | no price filed | 2017-03-09 | |
| 2017-03-07 | McMahon Robert W. Officer (Chief Financial Officer) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −711 1,444 owned after | no price filed | 2017-03-09 | |
| 2017-03-07 | Compton Eric B. Officer (COO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,185 2,407 owned after | no price filed | 2017-03-09 | |
| 2017-03-01 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −237,500 0 owned after | no price filed | 2017-11-09 | |
| 2017-02-02 | Griffin John M. Officer (General Counsel) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,343 2,686 owned after | no price filed | 2017-02-03 | |
| 2017-02-02 | Griffin John M. Officer (General Counsel) | 4 | Restricted Stock Unit Award (Right To Receive) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,033 2,066 owned after | no price filed | 2017-02-03 |